Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Summary
The global Age-related Macular Degeneration Market is expected to witness a CAGR of xx% over the forecast period 2021-2027 and is expected to reach US$ xx million in 2027, from US$ xx million in 2020.
Overview
Age-related macular degeneration is a condition that affects the central vision of a person. AMD may result in either severe loss of central vision or a slower progression of the disease with no loss of vision. Risk factors for AMD are being over 50 years old, never smoking, having high blood cholesterol, and eating a high saturated fat diet. However, not everyone who gets AMD gets it at the same time and experience the same symptoms. People with early and late forms of AMD have a higher risk of getting AMD later in life. The global age-related macular degeneration market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global age-related macular degeneration market is expected to witness significant growth during the forecast period, owing to rising geriatric population.
Market Drivers
Increasing cases of retinal disorders are expected to drive growth of the global age-related macular degeneration market during the forecast period. There are different types of retinal disorders including macular degeneration, retinal tear, macular hole, diabetic retinopathy, and retinal detachment. According to the BrightFocus Foundation, around 60 million people suffer vision loss due to macular degeneration. According to the same source, the number of people living with macular degeneration is expected to reach 196 million worldwide by 2020 and increase to 288 million by 2040. As a result of this, the demand for adequate treatment has increased rapidly. Hence, such factors are expected to drive growth of the global age-related macular degeneration market during the forecast period. Furthermore, rising geriatric population is expected to propel the global age-related degeneration market growth over the forecast period.
Market Restraint
Increasing use of off-label drugs and lack of awareness regarding AMD is expected to hinder the global age-related macular degeneration market growth over the forecast period.
Regional Insights
Among regions, North America is expected to witness significant growth in the global age-related macular desecration market during the forecast period. This is owing to increasing prevalence of hypertension and obesity as well as rising healthcare expenditure in the region. Furthermore, Europe is expected to register a robust growth rate, owing to growing geriatric population and high prevalence of lifestyle diseases in the region.
Competitive Section
Key companies involved in the global age-related macular degeneration market are Bayer HealthCare, F. Hoffmann-La Roche, Novartis, Alcon, Allergan, Gilead Sciences, Avalanche, and Neurotech Pharmaceuticals.
For instance, in September 2021, Samsung Bioepis received the U.S. Food and Drug Administration (FDA) approval for Byooviz as the first biosimilar Lucentis for the treatment of several eye diseases including age-related macular degeneration.
The Age-related Macular Degeneration Market report highlights product development and growth strategies such as mergers and acquisitions adopted by market players along with SWOT Analysis, PEST, and Porter’s Five Forces analyses of the Age-related Macular Degeneration Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Bayer HealthCare
- F. Hoffmann-La Roche
- Novartis
- Regeneron Pharmaceuticals
- Alcon
- Allergan
- Avalanche
- Bausch+Lomb
- Gilead Sciences
- Iconic Therapeutics
- Neurotech Pharmaceuticals
- Ohr Pharmaceutical
By Product Type, the market is primarily segmented into:
By Applications, the market is segmented into:
- Drugstore
- Hospital
- Others
The report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
The objective of the Age-related Macular Degeneration Market Report:
- To assess the size of the market by value and volume
- Analyze the Age-related Macular Degeneration Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Age-related Macular Degeneration Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of-the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact the growth of the Age-related Macular Degeneration Market
The Age-related Macular Degeneration Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Age-related Macular Degeneration Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type, and application, 2020 are considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Age-related Macular Degeneration Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Age-related Macular Degeneration Market Share by Application: 2021 VS 2027
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Age-related Macular Degeneration Market
1.6.1 How the Covid-19 is Affecting the Age-related Macular Degeneration Market
1.6.1.1 Age-related Macular Degeneration Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Age-related Macular Degeneration Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Age-related Macular Degeneration Market Perspective (2015-2027)
2.2 Age-related Macular Degeneration Market Growth Trends by Regions
2.2.1 Age-related Macular Degeneration Market Size by Regions: 2015 VS 2021 VS 2027
2.2.2 Age-related Macular Degeneration Market Historic Market Share by Regions (2015-2021)
2.2.3 Age-related Macular Degeneration Market Forecasted Market Size by Regions (2021-2027)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Age-related Macular Degeneration Market Growth Strategy
2.3.6 Primary Interviews with Key Age-related Macular Degeneration Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Age-related Macular Degeneration Market Players by Market Size
3.1.1 Global Top Age-related Macular Degeneration Market Players by Revenue (2015-2021)
3.1.2 Global Age-related Macular Degeneration Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Age-related Macular Degeneration Market Concentration Ratio
3.2.1 Global Age-related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Age-related Macular Degeneration Market Revenue in 2019
3.3 Age-related Macular Degeneration Market Key Players Head office and Area Served
3.4 Key Players Age-related Macular Degeneration Market Product Solution and Service
3.5 Date of entering into Age-related Macular Degeneration Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2027)
4.1 Global Age-related Macular Degeneration Market Historic Market Size by Type (2015-2021)
4.2 Global Age-related Macular Degeneration Market Forecasted Market Size by Type (2021-2027)
5 Age-related Macular Degeneration Market Breakdown Data by Application (2015-2027)
5.1 Global Age-related Macular Degeneration Market Size by Application (2015-2021)
5.2 Global Age-related Macular Degeneration Market Forecasted Market Size by Application (2021-2027)
6 North America
6.1 North America Age-related Macular Degeneration Market Size (2015-2021)
6.2 Age-related Macular Degeneration Market Key Players in North America (2019-2021)
6.3 North America Age-related Macular Degeneration Market Size by Type (2015-2021)
6.4 North America Age-related Macular Degeneration Market Size by Application (2015-2021)
7 Europe
7.1 Europe Age-related Macular Degeneration Market Size (2015-2021)
7.2 Age-related Macular Degeneration Market Key Players in Europe (2019-2021)
7.3 Europe Age-related Macular Degeneration Market Size by Type (2015-2021)
7.4 Europe Age-related Macular Degeneration Market Size by Application (2015-2021)
8 China
8.1 China Age-related Macular Degeneration Market Size (2015-2021)
8.2 Age-related Macular Degeneration Market Key Players in China (2019-2021)
8.3 China Age-related Macular Degeneration Market Size by Type (2015-2021)
8.4 China Age-related Macular Degeneration Market Size by Application (2015-2021)
9 Japan
9.1 Japan Age-related Macular Degeneration Market Size (2015-2021)
9.2 Age-related Macular Degeneration Market Key Players in Japan (2019-2021)
9.3 Japan Age-related Macular Degeneration Market Size by Type (2015-2021)
9.4 Japan Age-related Macular Degeneration Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Age-related Macular Degeneration Market Size (2015-2021)
10.2 Age-related Macular Degeneration Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Age-related Macular Degeneration Market Size by Type (2015-2021)
10.4 Southeast Asia Age-related Macular Degeneration Market Size by Application (2015-2021)
11 India
11.1 India Age-related Macular Degeneration Market Size (2015-2021)
11.2 Age-related Macular Degeneration Market Key Players in India (2019-2021)
11.3 India Age-related Macular Degeneration Market Size by Type (2015-2021)
11.4 India Age-related Macular Degeneration Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Age-related Macular Degeneration Market Size (2015-2021)
12.2 Age-related Macular Degeneration Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Age-related Macular Degeneration Market Size by Type (2015-2021)
12.4 Central & South America Age-related Macular Degeneration Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Age-related Macular Degeneration Market Introduction
13.4 Age-related Macular Degeneration Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Age-related Macular Degeneration Market Key Market Segments
Table 2. Key Players Covered: Ranking by Age-related Macular Degeneration Market Revenue
Table 3. Ranking of Global Top Age-related Macular Degeneration Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Age-related Macular Degeneration Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Age-related Macular Degeneration Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Age-related Macular Degeneration Market Players to Combat Covid-19 Impact
Table 10. Global Age-related Macular Degeneration Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 11. Global Age-related Macular Degeneration Market Size by Regions (US$ Million): 2021 VS 2027
Table 12. Global Age-related Macular Degeneration Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Age-related Macular Degeneration Market Share by Regions (2015-2021)
Table 14. Global Age-related Macular Degeneration Market Forecasted Market Size by Regions (2021-2027) (US$ Million)
Table 15. Global Age-related Macular Degeneration Market Share by Regions (2021-2027)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Age-related Macular Degeneration Market Growth Strategy
Table 20. Main Points Interviewed from Key Age-related Macular Degeneration Market Players
Table 21. Global Age-related Macular Degeneration Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Age-related Macular Degeneration Market Share by Players (2015-2021)
Table 23. Global Top Age-related Macular Degeneration Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-related Macular Degeneration Market as of 2019)
Table 24. Global Age-related Macular Degeneration Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Age-related Macular Degeneration Market Product Solution and Service
Table 27. Date of entering into Age-related Macular Degeneration Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Age-related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 30. Global Age-related Macular Degeneration Market Size Share by Type (2015-2021)
Table 31. Global Age-related Macular Degeneration Market Revenue Market Share by Type (2021-2027)
Table 31. Global Age-related Macular Degeneration Market Size Share by Application (2015-2021)
Table 33. Global Age-related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 34. Global Age-related Macular Degeneration Market Size Share by Application (2021-2027)
Table 35. North America Key Players Age-related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Age-related Macular Degeneration Market Share (2019-2021)
Table 37. North America Age-related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 38. North America Age-related Macular Degeneration Market Share by Type (2015-2021)
Table 39. North America Age-related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 40. North America Age-related Macular Degeneration Market Share by Application (2015-2021)
Table 41. Europe Key Players Age-related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Age-related Macular Degeneration Market Share (2019-2021)
Table 43. Europe Age-related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Age-related Macular Degeneration Market Share by Type (2015-2021)
Table 45. Europe Age-related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Age-related Macular Degeneration Market Share by Application (2015-2021)
Table 47. China Key Players Age-related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Age-related Macular Degeneration Market Share (2019-2021)
Table 49. China Age-related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 50. China Age-related Macular Degeneration Market Share by Type (2015-2021)
Table 51. China Age-related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 52. China Age-related Macular Degeneration Market Share by Application (2015-2021)
Table 53. Japan Key Players Age-related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Age-related Macular Degeneration Market Share (2019-2021)
Table 55. Japan Age-related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Age-related Macular Degeneration Market Share by Type (2015-2021)
Table 57. Japan Age-related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Age-related Macular Degeneration Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Age-related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Age-related Macular Degeneration Market Share (2019-2021)
Table 61. Southeast Asia Age-related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Age-related Macular Degeneration Market Share by Type (2015-2021)
Table 63. Southeast Asia Age-related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Age-related Macular Degeneration Market Share by Application (2015-2021)
Table 65. India Key Players Age-related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Age-related Macular Degeneration Market Share (2019-2021)
Table 67. India Age-related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 68. India Age-related Macular Degeneration Market Share by Type (2015-2021)
Table 69. India Age-related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 70. India Age-related Macular Degeneration Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Age-related Macular Degeneration Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Age-related Macular Degeneration Market Share (2019-2021)
Table 73. Central & South America Age-related Macular Degeneration Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Age-related Macular Degeneration Market Share by Type (2015-2021)
Table 75. Central & South America Age-related Macular Degeneration Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Age-related Macular Degeneration Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Age-related Macular Degeneration Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Age-related Macular Degeneration Market Share by Type: 2021 VS 2027
Figure 2. Global Age-related Macular Degeneration Market Share by Application: 2021 VS 2027
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Age-related Macular Degeneration Market Report Years Considered
Figure 8. Global Age-related Macular Degeneration Market Size YoY Growth 2015-2027 (US$ Million)
Figure 9. Global Age-related Macular Degeneration Market Share by Regions: 2021 VS 2027
Figure 10. Global Age-related Macular Degeneration Market Share by Regions (2021-2027)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Age-related Macular Degeneration Market Share by Players in 2019
Figure 13. Global Top Age-related Macular Degeneration Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Age-related Macular Degeneration Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Age-related Macular Degeneration Market Revenue in 2019
Figure 15. North America Age-related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Age-related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Age-related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Age-related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Age-related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Age-related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Age-related Macular Degeneration Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
